» Articles » PMID: 33230860

Evaluation of the SPECTRUM Training Programme for Real-time Continuous Glucose Monitoring: A Real-world Multicentre Prospective Study in 120 Adults with Type 1 Diabetes

Overview
Journal Diabet Med
Specialty Endocrinology
Date 2020 Nov 24
PMID 33230860
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Comprehensive knowledge, specific skills and data-analysis competences are prerequisites for the successful use of continuous glucose monitoring (CGM) systems. SPECTRUM is a structured training programme for real-time CGM (rtCGM) consisting of a web-based introduction and six group sessions of 90 min each. The 'CGM-TRAIN study' evaluated the efficacy and acceptance of SPECTRUM and rtCGM systems among adults with insulin therapy.

Methods: Participants (n = 120) were recruited from 10 German diabetes centres in which they were treated under usual care conditions. Outcome measures were rtCGM knowledge, practical skills, satisfaction with the training programme, satisfaction and acceptance of rtCGM system and glycaemic control. Data were collected at study entry, after training completion and at 6-month follow-up.

Results: All participants were diagnosed with type 1 diabetes (56% women, mean age 42.4 ± 13.4 years, diabetes duration 21.6 ± 11.6 years), 110 participants completed the course. After training completion, rtCGM-specific knowledge had improved by 43% (scale: 0-40 points) from 21.2 ± 7.6 to 30.4 ± 4.5 points; p < 0.001. The knowledge-level persisted until follow-up (29.4 ± 4.5). Participants were able to master nearly all the practical requirements of the technology. In addition, rtCGM was highly accepted, and participants were motivated to use their systems continuously. HbA improved slightly from 61 ± 14 mmol/mol (7.7 ± 1.3%) before training to 60 ± 14 mmol/mol (7.6 ± 1.3%) at follow-up (p = 0.04). The training programme itself was favourably rated by participants.

Conclusions: Under usual out-patient daily care conditions, the training programme SPECTRUM improved knowledge and skills about rtCGM in adults with type 1 diabetes. This was associated with a reduced HbA , high satisfaction and acceptance of rtCGM (Clinical Trials Registry no.: DRKS00014380).

Citing Articles

Long-Term Glycemic Control Improvement After the Home and Self-Care Program for Patients With Type 1 Diabetes: Real-World-Based Cohort Study.

Koo D, Moon S, Moon S, Park S, Rhee E, Lee W J Med Internet Res. 2024; 26:e60023.

PMID: 39259960 PMC: 11425018. DOI: 10.2196/60023.


How to Use Continuous Glucose Monitoring Efficiently in Diabetes Management: Opinions and Recommendations by German Experts on the Status and Open Questions.

Thomas A, Haak T, Tombek A, Kulzer B, Ehrmann D, Kordonouri O J Diabetes Sci Technol. 2024; :19322968241267768.

PMID: 39129243 PMC: 11571508. DOI: 10.1177/19322968241267768.


Unveiling the interplay between rational, psychological and functional factors in continuous glucose monitoring early adoption: Novel evidence from the Dexcom ONE case in Italy.

Zoccarato F, Manzoni M, Minotti D, Lettieri E, Boaretto A BMC Health Serv Res. 2024; 24(1):747.

PMID: 38890619 PMC: 11186290. DOI: 10.1186/s12913-024-11195-6.


Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial.

Kim J, Jin S, Sim K, Kim B, Cho J, Moon J Diabetologia. 2024; 67(7):1223-1234.

PMID: 38639876 DOI: 10.1007/s00125-024-06152-1.


[Insulin pump therapy and continuous glucose monitoring].

Schutz-Fuhrmann I, Rami-Merhar B, Frohlich-Reiterer E, Hofer S, Tauschmann M, Mader J Wien Klin Wochenschr. 2023; 135(Suppl 1):53-61.

PMID: 37101025 PMC: 10132921. DOI: 10.1007/s00508-023-02165-9.